TLSA (Tiziana Life Sciences) Current Accrued Expense : $1.44 Mil (As of Jun. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Tiziana Life Sciences Current Accrued Expense?

Tiziana Life Sciences's Current Accrued Expense for the quarter that ended in Jun. 2024 was $1.44 Mil.

Tiziana Life Sciences's quarterly Current Accrued Expense increased from Jun. 2023 ($0.82 Mil) to Dec. 2023 ($2.25 Mil) but then declined from Dec. 2023 ($2.25 Mil) to Jun. 2024 ($1.44 Mil).

Tiziana Life Sciences's annual Current Accrued Expense declined from Dec. 2021 ($1.78 Mil) to Dec. 2022 ($1.57 Mil) but then increased from Dec. 2022 ($1.57 Mil) to Dec. 2023 ($2.25 Mil).

Tiziana Life Sciences Current Accrued Expense Historical Data

The historical data trend for Tiziana Life Sciences's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tiziana Life Sciences Current Accrued Expense Chart

Tiziana Life Sciences Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Current Accrued Expense

Get a 7-Day Free Trial

2.19

2.22

1.78

1.57

2.25

Tiziana Life Sciences Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Current Accrued Expense	Get a 7-Day Free Trial															0.85	1.57	0.82	2.25	1.44

Tiziana Life Sciences Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

Tiziana Life Sciences Current Accrued Expense Related Terms

Thank you for viewing the detailed overview of Tiziana Life Sciences's Current Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Tiziana Life Sciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Tiziana Life Sciences Ltd (NAS:TLSA) » Definitions » Current Accrued Expense

Comparable Companies

Traded in Other Exchanges

0RP:Germany

Address

2 Church Street, Clarendon House, Hamilton, BMU, HM 11

Website

https://www.tizianalifesciences.com

Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in the developing transformative therapies for neurodegenerative and lung diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.